PMI — Picard Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $19.17m
- $18.28m
- $4.94m
Annual cashflow statement for Picard Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -11.2 | -15.6 | -21.1 | -27 |
| Depreciation | ||||
| Non-Cash Items | 1.83 | 1.07 | 7.99 | 14.4 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -1.93 | 3.28 | 0.963 | -3.2 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Cash from Operating Activities | -10.7 | -10.6 | -11.9 | -15.7 |
| Capital Expenditures | -0.029 | -0.007 | 0 | — |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -0.008 | -0.002 | 0 | — |
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -0.037 | -0.009 | 0 | — |
| Financing Cash Flow Items | 0 | 2.65 | — | -1.49 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 5.52 | 10.8 | 11.7 | 27.1 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -5.1 | 0.092 | -0.148 | 11.4 |